Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?

The COVID-19 pandemic paused many HIV prevention efforts, which helped fuel last year's rise in new infections. President Donald Trump's federal funding cuts threaten to further hamper those efforts.